SynthesisBMC urology2019

Hypertension as a prognostic factor in metastatic renal cell carcinoma treated with tyrosine kinase inhibitors: a systematic review and meta-analysis.

Yu Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.